Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients. Gebeyehu GG, Fiske J, Liu E, Limdi JK, et al. Dig Dis Sci 2022 Nov 27:1-12. doi: 10.1007/s10620-022-07770.

Read + Share

Amedeo Smart

Independent Medical Education

Gebeyehu GG, Fiske J, Liu E, Limdi JK, et al. Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients. Dig Dis Sci 2022 Nov 27:1-12. doi: 10.1007/s10620-022-07770.
PMID: 36436155